iBio to Present at Brazilian Ministry of Health’s Plant-Made Pharmaceutical Meeting
December 03, 2018 08:00 ET
|
iBio, Inc.
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a developer and manufacturer of biotherapeutics, today announced that it will present at the Plant-Based Technology...
iBio and CC-Pharming Hold First Design and Strategy Meeting
October 02, 2018 08:00 ET
|
iBio, Inc.
NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the beginning of a four-day design and strategic planning meeting with executives and technical experts...
iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance
August 22, 2018 16:10 ET
|
iBio, Inc.
NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced that NYSE Regulation has accepted the Company’s plan to regain compliance with...
iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China
July 09, 2018 08:00 ET
|
iBio, Inc.
NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint...
iBio, Inc. Closes $16,000,000 Public Offering
June 26, 2018 18:59 ET
|
iBio, Inc.
NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”), today announced that it has closed its previously announced underwritten public offering with...
iBio, Inc. Prices $16,000,000 Public Offering
June 22, 2018 07:26 ET
|
iBio, Inc.
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” OR THE “COMPANY”), today announced the pricing of an underwritten public offering with expected total gross...
iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split
June 08, 2018 16:30 ET
|
iBio, Inc.
NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today that its previously announced 1-for-10 reverse stock split of common stock...
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
June 08, 2018 16:01 ET
|
iBio, Inc.
NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today that on June 6, 2018, the Company received a letter from NYSE American LLC...
iBio and ONEWAY Diagnostica Develop New Products for Brazil
June 05, 2018 08:30 ET
|
iBio, Inc.
NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced a joint product development, manufacturing and revenue sharing agreement with ONEWAY Diagnostica of Brazil...
iBio, Inc. Announces Reverse Stock Split
May 31, 2018 08:30 ET
|
iBio, Inc.
NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today a reverse split of its Common Stock, par value $0.001 per share (the “Common...